Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
304,176
-
Share change
-
+60,497
-
Total reported value
-
$303,734
-
Price per share
-
$1.00
-
Number of holders
-
16
-
Value change
-
+$61,202
-
Number of buys
-
9
-
Number of sells
-
6
Institutional Holders of Hoth Therapeutics, Inc. - COM NEW (HOTH) as of Q1 2025
As of 31 Mar 2025,
Hoth Therapeutics, Inc. - COM NEW (HOTH) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
304,176 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, VANGUARD GROUP INC, Virtu Financial LLC, TWO SIGMA SECURITIES, LLC, Foundations Investment Advisors, LLC, HRT FINANCIAL LP, TWO SIGMA INVESTMENTS, LP, MORGAN STANLEY, and OSAIC HOLDINGS, INC..
This page lists
16
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.